Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib	ovarian carcinosarcoma	Recruiting	Phase 2 / Phase 3	2026-09-09		NCT03651206

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
ARCAGY/ GINECO GROUP	14
Tesaro, Inc.	16

36 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Azienda Ospedaliera Ordine Mauriziano Di Torino	Torino	Italy	8
Azienda Ospedaliera Per L'Emergenza Cannizzaro	Catania	Italy	1
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico	Bologna	Italy	4
Centre Eugène Marquis	Rennes	France	13
Centre François Baclesse	Caen	France	23
Centre Georges François Leclerc	Dijon	France	42
Centre Hospitalier Universitaire de Nîmes, Institut de Cancérologie du GARD	Nîmes	France	1
Centre Jean Perrin	Clermont-Ferrand	France	10
Centre Léon Bérard	Lyon	France	1
Centre Oscar Lambret	Lille	France	41
Centre Régional de Lutte contre le cancer - Institut Bergonié	Bordeaux	France	1
CHRU Jean Minjoz	Besançon	France	4
CHU de BREST - Hôpital Cavale Blanche	Brest	France	4
CHU de Limoges - Hôpital Dupuytren	Limoges	France	8
CHU Saint-Etienne - Pôle de Cancérologie	Saint-Priest-en-Jarez	France	2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Roma	Italy	61
Groupe Hospitalier des Diaconesses Croix Saint-Simon	Paris	France	1
Hopital Milétrie - Centre Hospitalier Universitaire Poitiers	Poitiers	France	1
Hospital Clinico Universitario de Valencia	Valencia	Spain	109
Hospital Universitario 12 de Octubre	Madrid	Spain	359
Hospital Universitario Ramon y Cajal	Madrid	Spain	141
Hospital Virgen de la Arrixaca	Murcia	Spain	4
Humanitas Mirasole S.p.A.	Milan	Italy	1
Hôpital Privé du Confluent S.A.S.	Nantes	France	2
Hôpitaux Universitaires de Strasbourg	Strasbourg	France	24

Clinical trials